Back to mobile site

Mountain Valley MD closes CAD $2M private placement and debt settlement

April 15, 2026 8:00 AM EDT

Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTC: MVMDF) closed a non-brokered private placement raising CAD $2 million and completed two debt settlement transactions totaling CAD $485,000, according to a company statement.



The private placement involved issuing 80 million units at CAD $0.025 per unit. Each unit consists of one common share and one warrant exercisable at CAD $0.08 per share for 12 months. The warrants may be accelerated if the company's share price reaches CAD $0.12 for 10 consecutive trading days.



The placement attracted new investors with industry experience, participating on the same terms as other subscribers. No finder's fees were paid for the transaction.



Concurrently, Mountain Valley MD settled CAD $485,000 in outstanding debt through share issuances. The first transaction involved issuing 22.6 million shares at CAD $0.017 per share to settle CAD $385,000. The second transaction issued 2 million shares at CAD $0.05 per share to settle CAD $100,000.



"This financing represents an important step in strengthening our balance sheet and positioning MVMD for continued execution," said Dennis Hancock, President and CEO.



All securities are subject to a four-month hold period expiring August 15, 2026. The company plans to use proceeds for general working capital purposes.



Mountain Valley MD develops oral formulation and delivery technologies, including its patented Quicksome and Quicksol technologies, and licenses Agrarius agricultural technology.


You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

Definitive Agreement